BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32529521)

  • 1. Obstructive sleep apnea syndrome-related hypertension and sarcopenia: a brief glance on the renin-angiotensin-aldosterone system.
    Ekiz T; Kara M; Ricci V; Özçakar L
    Sleep Breath; 2021 Jun; 25(2):1159-1161. PubMed ID: 32529521
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence and implications of the renin-angiotensin-aldosterone system in obstructive sleep apnea: An updated systematic review and meta-analysis.
    Loh HH; Lim QH; Chai CS; Goh SL; Lim LL; Yee A; Sukor N
    J Sleep Res; 2023 Feb; 32(1):e13726. PubMed ID: 36104933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced cardiac remodeling in sleep apnea syndrome: involvement of the renin-angiotensin-aldosterone system.
    Miwa Y; Sasaguri T
    Hypertens Res; 2007 Dec; 30(12):1147-9. PubMed ID: 18344618
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between COVID-19 and obesity.
    Ekiz T; Pazarlı AC
    Diabetes Metab Syndr; 2020; 14(5):761-763. PubMed ID: 32505980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Contribution of Carotid Body-Induced Sympathetic and Renin-Angiotensin System Overflow to Pulmonary Hypertension in Intermittent Hypoxia.
    Iturriaga R; Castillo-Galán S
    Curr Hypertens Rep; 2019 Oct; 21(11):89. PubMed ID: 31599367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstructive sleep apnea syndrome and hypertension: ambulatory blood pressure.
    Kario K
    Hypertens Res; 2009 Jun; 32(6):428-32. PubMed ID: 19494815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive therapy for patients with obstructive sleep apnea.
    Ziegler MG; Milic M; Sun P
    Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):50-5. PubMed ID: 21326007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of obstructive sleep apnea syndrome on renin and aldosterone.
    Lykouras D; Theodoropoulos K; Sampsonas F; Lagiou O; Lykouras M; Spiropoulou A; Flordellis C; Alexandrides T; Karkoulias K; Spiropoulos K
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4164-70. PubMed ID: 26592843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep apnea and hypertension.
    Hoffmann M; Bybee K; Accurso V; Somers VK
    Minerva Med; 2004 Aug; 95(4):281-90. PubMed ID: 15334042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstructive sleep apnoea as a cause of nocturnal nondipping blood pressure: recent evidence regarding clinical importance and underlying mechanisms.
    Crinion SJ; Ryan S; McNicholas WT
    Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28077479
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypertension in obesity.
    Kurukulasuriya LR; Stas S; Lastra G; Manrique C; Sowers JR
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):647-62, ix. PubMed ID: 18775357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep apnea, aldosterone, and resistant hypertension.
    Pimenta E; Calhoun DA; Oparil S
    Prog Cardiovasc Dis; 2009; 51(5):371-80. PubMed ID: 19249443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary aldosteronism and obstructive sleep apnea: What do we know thus far?
    Loh HH; Sukor N
    Front Endocrinol (Lausanne); 2022; 13():976979. PubMed ID: 36246876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular abnormalities in patients with obstructive sleep apnoea syndrome].
    Myśliński W; Dybała A; Mosiewicz J; Prystupa A; Hanzlik J
    Wiad Lek; 2005; 58(1-2):78-83. PubMed ID: 15991558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and pharmacologic approach to patients with resistant hypertension.
    Adams M; Bellone JM; Wright BM; Rutecki GW
    Postgrad Med; 2012 Jan; 124(1):74-82. PubMed ID: 22314117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the kidney yet another potential end-organ casualty of obstructive sleep apnea?
    Phillips CL; Laher I; Yee BJ
    Am J Respir Crit Care Med; 2015 Oct; 192(7):779-81. PubMed ID: 26426783
    [No Abstract]   [Full Text] [Related]  

  • 17. Obstructive sleep apnea syndrome (OSAS) and hypertension: pathogenic mechanisms and possible therapeutic approaches.
    Zhang W; Si LY
    Ups J Med Sci; 2012 Nov; 117(4):370-82. PubMed ID: 23009224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of continuous positive airway pressure therapy on renin-angiotensin system activity in obstructive sleep apnea.
    Nicholl DD; Hanly PJ; Poulin MJ; Handley GB; Hemmelgarn BR; Sola DY; Ahmed SB
    Am J Respir Crit Care Med; 2014 Sep; 190(5):572-80. PubMed ID: 25033250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The underlying mechanisms for development of hypertension in the metabolic syndrome.
    Yanai H; Tomono Y; Ito K; Furutani N; Yoshida H; Tada N
    Nutr J; 2008 Apr; 7():10. PubMed ID: 18416854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstructive sleep apnea and hypertension: the role of gut microbiome.
    Šiarnik P; Klobučníková K; Mucska I; Hlucháňová A; Hanus O; Turčáni P; Kollár B
    Vnitr Lek; 2020; 66(7):415-419. PubMed ID: 33380119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.